Should a patient with adrenal insufficiency (AI) taking cortisol replacement therapy, such as hydrocortisone, hold their morning dose before a blood test to check cortisol levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should Patients Hold Their Morning Cortisol Dose Before Testing?

Yes, patients with adrenal insufficiency on cortisol replacement therapy must hold their morning hydrocortisone dose before checking cortisol levels, as exogenous steroids will falsely elevate the measured cortisol and make the test completely uninterpretable. 1

Why This Matters

  • Hydrocortisone must be held for 24 hours before testing, while other synthetic steroids like prednisone require even longer washout periods before endogenous adrenal function can be accurately assessed 1
  • Morning cortisol measurements in patients actively taking corticosteroids are not diagnostic because the assay measures both endogenous cortisol and therapeutic steroids, with cross-reactivity varying by assay 2
  • Therapeutic glucocorticoid use causes iatrogenic secondary adrenal insufficiency by suppressing the hypothalamic-pituitary-adrenal axis, making cortisol levels unreliable without proper washout 1

The Clinical Problem

  • If you're checking a morning cortisol to assess whether a patient still needs replacement therapy or to evaluate HPA axis recovery, the test is meaningless if they've taken their dose 1
  • Patients on corticosteroids for management of other conditions will have low morning cortisol as a result of iatrogenic secondary adrenal insufficiency, and ACTH will also be low in these patients 3
  • Laboratory confirmation of adrenal insufficiency should not be attempted in patients given corticosteroids until treatment is ready to be discontinued 2

Practical Testing Protocol

  • For HPA axis recovery testing: Have the patient hold hydrocortisone for 24 hours, then draw morning (8 AM) cortisol and ACTH 1
  • For ACTH stimulation testing: The patient should hold their morning dose, present fasting, and you can perform the cosyntropin test to assess adrenal reserve 1
  • In cases of clinical uncertainty with ongoing steroid use, opt for empiric glucocorticoid replacement and test for ongoing need at 3 months rather than attempting diagnostic testing while on steroids 1

Critical Safety Considerations

  • Never delay treatment of suspected acute adrenal insufficiency for diagnostic procedures—if the patient is clinically unstable with suspected adrenal crisis, give IV hydrocortisone 100 mg immediately 1
  • If you need to treat suspected adrenal crisis but still want to perform diagnostic testing later, use dexamethasone 4 mg IV instead of hydrocortisone, as dexamethasone does not interfere with cortisol assays 3, 1
  • The Endocrine Society recommends testing for HPA axis recovery after 3 months of maintenance therapy with hydrocortisone in patients with isolated central adrenal insufficiency from steroid use 1

When Testing Isn't the Right Question

  • If the patient is on established replacement therapy for confirmed adrenal insufficiency, there's usually no reason to check cortisol levels—the diagnosis is already made 3
  • Approximately one-third to one-half of patients taking 5-20 mg prednisolone daily fail to achieve target cortisol concentrations on short Synacthen testing, even when they may have adequate adrenal reserve, demonstrating the test's unreliability in this population 1
  • Wait until the patient has been weaned off corticosteroids before performing definitive HPA axis testing 1

Related Questions

What is the management of hypotension in patients with adrenal insufficiency?
What are the side effects of hydrocortisone (cortisol) in patients with adrenal insufficiency?
At what time should a 3rd dose of hydrocortisone (cortisol replacement) be administered in an adrenal insufficiency patient to limit effects on sleep?
What is the recommended approach to cortisol replacement therapy in adults, particularly those with a history of adrenal insufficiency?
Should I double my hydrocortisone (cortisol replacement) dose from 10mg when I'm sick due to adrenal insufficiency?
How do I transition a patient taking hydromorphone (Dilaudid) 6 mg orally (PO) twice a day (BID) to Butrans (buprenorphine) patch?
What are the symptoms of an antihistamine (anti-allergic medication) overdose in different patient populations, such as the elderly, young children, and individuals with pre-existing liver or kidney disease?
What is the appropriate dosing of Rocephin (Ceftriaxone) for a patient with a severe infection and potentially impaired renal function?
Can Tirzepatide (a medication for type 2 diabetes) cause hair thinning in patients with type 2 diabetes?
Are there any topical anesthetics, such as lidocaine (a local anesthetic), that can be safely used on the vagina for a female patient with no prior history of using topical anesthetics?
What is the workup for a patient with a lymph node enlargement and overlying skin discoloration, considering potential causes such as infection (e.g. tuberculosis, cat-scratch disease) or malignancy (e.g. lymphoma, metastatic cancer)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.